Search research articles
Contact Us
Filters
Showing results (91-100 of 749) with videos related to
Page
of 75
Sort By:
Seminars in Thrombosis and Hemostasis
|
February 7, 2014
Response to "Rates of inhibitor development in previously untreated patients with severe hemophilia a treated with plasma-derived or recombinant factor VIII: no proof of difference or proof of no difference?"
Massimo Franchini, Carlo Mengoli
Infectious Diseases (London, England)
|
March 29, 2024
Towards the identification of the correct place for convalescent plasma among COVID-19 therapies
Massimo Franchini, Daniele Focosi
Expert Review of Hematology
|
May 6, 2024
Inhibitor eradication and treatment for acquired hemophilia A
Massimo Franchini, Daniele Focosi
Helicobacter
|
February 5, 2005
Onset of idiopathic thrombocythemia after Helicobacter pylori eradication
Dino Veneri, Massimo Franchini
Thrombosis and Haemostasis
|
June 6, 2007
The growing impact of publications in haemostasis and thrombosis journals
Giuseppe Lippi, Massimo Franchini
Helicobacter
|
July 24, 2004
Helicobacter pylori infection and immune thrombocytopenic purpura: an update
Massimo Franchini, Dino Veneri
The Hematology Journal : the Official Journal of the European Haematology Association
|
August 7, 2004
Iron-chelation therapy: an update
Massimo Franchini, Dino Veneri
Recenti Progressi in Medicina
|
April 23, 2005
[Inherited thrombophilia]
Massimo Franchini, Dino Veneri
Hematology (Amsterdam, Netherlands)
|
August 9, 2005
The antiphospholipid syndrome
Massimo Franchini, Dino Veneri
American Journal of Hematology
|
November 30, 2006
Acquired von Willebrand syndrome: an update
Massimo Franchini, Giuseppe Lippi
Page
of 75
Search research articles
Search
Showing results (91-100 of 749) with videos related to
Sort By:
Page
of 75
Seminars in Thrombosis and Hemostasis
|
February 7, 2014
Response to "Rates of inhibitor development in previously untreated patients with severe hemophilia a treated with plasma-derived or recombinant factor VIII: no proof of difference or proof of no difference?"
Massimo Franchini, Carlo Mengoli
Infectious Diseases (London, England)
|
March 29, 2024
Towards the identification of the correct place for convalescent plasma among COVID-19 therapies
Massimo Franchini, Daniele Focosi
Expert Review of Hematology
|
May 6, 2024
Inhibitor eradication and treatment for acquired hemophilia A
Massimo Franchini, Daniele Focosi
Helicobacter
|
February 5, 2005
Onset of idiopathic thrombocythemia after Helicobacter pylori eradication
Dino Veneri, Massimo Franchini
Thrombosis and Haemostasis
|
June 6, 2007
The growing impact of publications in haemostasis and thrombosis journals
Giuseppe Lippi, Massimo Franchini
Helicobacter
|
July 24, 2004
Helicobacter pylori infection and immune thrombocytopenic purpura: an update
Massimo Franchini, Dino Veneri
The Hematology Journal : the Official Journal of the European Haematology Association
|
August 7, 2004
Iron-chelation therapy: an update
Massimo Franchini, Dino Veneri
Recenti Progressi in Medicina
|
April 23, 2005
[Inherited thrombophilia]
Massimo Franchini, Dino Veneri
Hematology (Amsterdam, Netherlands)
|
August 9, 2005
The antiphospholipid syndrome
Massimo Franchini, Dino Veneri
American Journal of Hematology
|
November 30, 2006
Acquired von Willebrand syndrome: an update
Massimo Franchini, Giuseppe Lippi
Page
of 75